Biotech RadarJobs updated

COMPANY

Natera

HQ: Austin, TX source · natera.com ↗ · West Coast

FDA-cleared device company Past trials only

195 open jobs · last seen Oct 23, 2026 · 50 sources

Keywords: diagnostics molecular diagnostics oncology women's health Trisomy 21 Trisomy 13 Trisomy 18 Sex Chromosome Abnormalities Heart Transplant Failure and Rejection Melanoma Colorectal Cancer Microdeletion Syndromes Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen (for ER-positive Requirement) Vanishing Twin Non-Muscle Invasive Bladder Cancer NMIBC High-risk Non-Muscle Invasive Bladder Cancer Non-Hodgkin Lymphoma T-Cell Lymphoma Diffuse Large B-Cell Lymphoma High-Grade B-Cell Lymphoma Primary Mediastinal B-Cell Lymphoma Peripheral T-Cell Lymphoma Transformed Follicular Lymphoma Follicular Lymphoma Grade 3B Follicular Lymphoma Anaplastic Large Cell Lymphoma NSCLC (Advanced Non-small Cell Lung Cancer) NSCLC (Non-small Cell Lung Cancer) NSCLC (Non-small Cell Lung Carcinoma) NSCLC Melanoma (Skin) Stage IV CRC MSI High Colorectal Cancer DMMR Colorectal Cancer RCC Advanced Solid Tumors Cancer Kidney Transplant Immunosuppresion

Location: Austin, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

195+39 patient-care hiddenOpen jobs36Trials (company is sponsor)11NIH grants

Hiring

TitleLocation (from posting)Employer postedFirst seen
Scientist, IVD BioDevelopmentAustin, TXOct 22, 2026Oct 23, 2026
Supervisor, Prior AuthorizationsUS RemoteOct 22, 2026Oct 23, 2026
IT Helpdesk Specialist 2San Carlos, CAOct 22, 2026Oct 23, 2026
IT Helpdesk Specialist 2Austin, TXOct 22, 2026Oct 23, 2026
Lab Assistant ISan Carlos, CAOct 22, 2026Oct 23, 2026

See all 195 jobs

Trial and FDA signals

Job counts as of Oct 18, 2026. All trial and FDA signals

Timeline

  1. Trial start Not phased (device or behavioral study): A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumor source ↗
  2. Board tracked Radar started tracking this company’s job board (234 open jobs at last check). source ↗
  3. Trial start Not phased (device or behavioral study): Signatera Assessment in Early-Stage Endometrial Cancer source ↗
  4. Trial start Not phased (device or behavioral study): Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer source ↗
  5. Trial start —: Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) source ↗
  6. Trial start —: Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) source ↗
  7. Trial start Not phased (device or behavioral study): Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT) source ↗
  8. Trial start Not phased (device or behavioral study): Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer source ↗
  9. Partnership Partnership / licensing announced Jan 7, 2026. Source: company's own press page. source ↗
  10. Partnership Partnership / licensing announced Dec 12, 2025. Source: company's own press page. source ↗
  11. Trial start —: Sample Collection for Ongoing Research and Product Evaluation Study source ↗
  12. Trial start —: Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC) source ↗
  13. Trial start Not phased (device or behavioral study): A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy source ↗
  14. Trial start —: Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection source ↗
  15. Trial start —: EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) source ↗
  16. Trial start Not phased (device or behavioral study): Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation source ↗
  17. Trial start —: Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation source ↗
  18. Trial start —: LAMBDA 002 (Lung Registry) Study source ↗
  19. Trial start —: Prospera Test Evaluation in Cardiac Transplant (ProTECT) source ↗
  20. Trial start —: Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management. source ↗
  21. Trial start —: Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies source ↗
  22. Trial start Not phased (device or behavioral study): Renasight Clinical Application, Review and Evaluation (RenaCARE) Study source ↗
  23. Trial start —: BESPOKE Study of ctDNA Guided Immunotherapy source ↗
  24. Trial start —: BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer source ↗
  25. Trial start —: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) source ↗

Showing 25 of 39 dated events.

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 195

39 patient-care jobs hidden (phlebotomy, plasma-center, nursing and similar care roles; 234 open jobs in total).

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Scientist, IVD BioDevelopmentAustin, TXOct 22, 2026Oct 23, 2026Not stated
Supervisor, Prior AuthorizationsUS RemoteOct 22, 2026Oct 23, 2026Not stated
IT Helpdesk Specialist 2San Carlos, CAOct 22, 2026Oct 23, 2026Not stated
IT Helpdesk Specialist 2Austin, TXOct 22, 2026Oct 23, 2026Not stated
Lab Assistant ISan Carlos, CAOct 22, 2026Oct 23, 2026Not stated
Account Sales Representative (Orlando West)Orlando, FLOct 21, 2026Oct 22, 2026Not stated
Account Sales Representative (Orlando West)Orlando, FLOct 21, 2026Oct 22, 2026Not stated
CQV EngineerAustin, TXOct 21, 2026Oct 22, 2026Not stated
Associate CQV EngineerAustin, TXOct 21, 2026Oct 22, 2026Not stated
Account Sales RepresentativeModesto, CA; San Jose, CAOct 21, 2026Oct 22, 2026Not stated
Oncology Trial NavigatorUS RemoteOct 20, 2026Oct 21, 2026Not stated
Scientist R&DSan Carlos, CAOct 20, 2026Oct 21, 2026Not stated
Staff Scientist R&DSan Carlos, CAOct 20, 2026Oct 21, 2026Not stated
Senior Scientist R&DSan Carlos, CAOct 20, 2026Oct 21, 2026Not stated
Senior Lab Equipment TechAustin, TXOct 20, 2026Oct 21, 2026Not stated
Digital Product Manager, Tissue Acquisition ExperienceUS RemoteOct 20, 2026Oct 21, 2026Not stated
Sr HR Business PartnerUS RemoteOct 20, 2026Oct 21, 2026Not stated
Associate Clinical Oncology SpecialistShreveport, LA; Tyler, TXOct 20, 2026Oct 20, 2026Not stated
Associate Clinical Oncology SpecialistDallas, TXOct 20, 2026Oct 20, 2026Not stated
Enterprise Strategic Accounts ManagerChicago, IL; Madison, WI; Milwaukee, WIOct 19, 2026Oct 20, 2026Not stated
Clinical Oncology Specialist, BreastDallas, TX; Fort Worth, TXOct 19, 2026Oct 20, 2026Not stated
Clinical Oncology Specialist, BreastCincinnati, OH; Cleveland, OH; Lexington, KY; Louisville, KYOct 19, 2026Oct 20, 2026Not stated
Clinical Oncology Specialist, BreastPhiladelphia, PA; South JerseyOct 19, 2026Oct 20, 2026Not stated
Director of Bioinformatics and Machine LearningSan Carlos, CAOct 19, 2026Oct 20, 2026Not stated
PSC Manager - Olympia, WAUS RemoteOct 18, 2026Oct 19, 2026Not stated
Associate Clinical Oncology SpecialistLos Angeles, CA; Pasadena, CAOct 16, 2026Oct 17, 2026Not stated
Associate Clinical Oncology SpecialistSan Jose, CAOct 16, 2026Oct 17, 2026Not stated
Rare Disease SpecialistOakland, CA; San Francisco, CAOct 16, 2026Oct 17, 2026Not stated
Account Sales RepresentativeLafayette, LA; Lake Charles, LAOct 16, 2026Oct 17, 2026Not stated
Medical Science Liaison - Rare DiseaseUS RemoteOct 15, 2026Oct 16, 2026Not stated
Email Marketing Specialist-TempUS RemoteOct 15, 2026Oct 16, 2026Not stated
Principal AI EngineerUS RemoteOct 15, 2026Oct 23, 2026Not stated
Data Privacy ManagerUS RemoteOct 14, 2026Oct 15, 2026Mid
Data Privacy DirectorUS RemoteOct 14, 2026Oct 15, 2026Senior
Mobile Patient Services Specialist - San Antonio, TXSan Antonio, TXOct 14, 2026Oct 15, 2026Mid
Mobile Patient Services Specialist Lead - San Antonio, TXSan Antonio, TXOct 14, 2026Oct 15, 2026Senior
Clinical Oncology Specialist, GUPittsburgh, PAOct 14, 2026Oct 15, 2026Mid
Clinical Oncology Specialist, GUDetroit, MI; Indianapolis, INOct 14, 2026Oct 15, 2026Mid
Clinical Oncology Specialist, GUOrlando, FLOct 14, 2026Oct 15, 2026Mid
Clinical Oncology Specialist, GUDenver, CO; Phoenix, AZOct 14, 2026Oct 15, 2026Mid
Staff Biostatistician (Clinical Validation)San Carlos, CAOct 14, 2026Oct 15, 2026Senior
Staff Biostatistician (Clinical Validation)US RemoteOct 14, 2026Oct 15, 2026Senior
Director, ECD DevelopmentSan Carlos, CAOct 14, 2026Oct 15, 2026Senior
Senior Director, Development - ECD and MCED ProductsSan Carlos, CAOct 14, 2026Oct 15, 2026Senior
Clinical Oncology Specialist, H&NCleveland, OHOct 14, 2026Oct 15, 2026Mid
Clinical Oncology Specialist, GUWashington D.COct 14, 2026Oct 14, 2026Mid
Regional Director, GU Oncology SalesEast, US RegionOct 14, 2026Oct 14, 2026Senior
Regional Director, GU Oncology SalesWest, US RegionOct 14, 2026Oct 14, 2026Senior
Finance Functional Lead, Oracle Fusion CloudUS RemoteOct 13, 2026Oct 14, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

All 195 jobs →

Funding

Last 2 years.

Clinical trials (lead sponsor) 36

RecordTitlePhaseStatusStartPrimary completion
NCT07214532Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerNot phased (device or behavioral study)RecruitingMay 8, 2026May 15, 2032 (estimated)
NCT05004337Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin PregnanciesNot listedCompletedJul 22, 2021Nov 29, 2023 (actual)
NCT07763197Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)Not listedRecruitingJul 27, 20262032-07 (estimated)
NCT07750886Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)Not listedRecruitingJul 27, 20262032-04 (estimated)
NCT07689812A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Not phased (device or behavioral study)Not yet recruiting2026-122033-12 (estimated)
NCT07718633Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)Not phased (device or behavioral study)Not yet recruiting2026-072027-12 (estimated)
NCT07339384Signatera Assessment in Early-Stage Endometrial CancerNot phased (device or behavioral study)Not yet recruiting2026-102034-10 (estimated)
NCT07565857Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal CancerNot phased (device or behavioral study)Not yet recruiting2026-092028-09 (estimated)
NCT06808880EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)Not listedRecruitingJan 25, 20242027-04 (estimated)
NCT06414603A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial BiopsyNot phased (device or behavioral study)Active, not recruitingJun 10, 20242027-02 (estimated)
NCT07318051Sample Collection for Ongoing Research and Product Evaluation StudyNot listedRecruitingJul 21, 20252035-01 (estimated)
NCT07046585Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)Not listedRecruitingMay 30, 2025Jul 10, 2027 (estimated)
NCT05170425LAMBDA 002 (Lung Registry) StudyNot listedActive, not recruitingNov 4, 20222026-08 (estimated)
NCT05205551Prospera Test Evaluation in Cardiac Transplant (ProTECT)Not listedActive, not recruitingOct 1, 2021Oct 31, 2026 (estimated)
NCT03984747Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA DetectionNot listedCompletedSep 14, 2018Aug 23, 2024 (actual)
NCT06620627Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer DetectionNot listedRecruitingJan 26, 2024Jul 31, 2025 (estimated)
NCT05309382Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart TransplantationNot listedCompletedDec 12, 2022Oct 2, 2024 (actual)
NCT05312814Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.Not listedCompletedOct 1, 2021May 15, 2023 (actual)
NCT04761783BESPOKE Study of ctDNA Guided ImmunotherapyNot listedCompletedMay 28, 2021Dec 31, 2023 (actual)
NCT04091984The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)Not listedActive, not recruitingNov 6, 2019Oct 1, 2026 (estimated)
NCT05081739Donor-Derived Cell-free DNA to DETect REjection in Cardiac TransplantationNot phased (device or behavioral study)Withdrawn2023-012025-01 (estimated)
NCT04264702BESPOKE Study of ctDNA Guided Therapy in Colorectal CancerNot listedUnknown status (ClinicalTrials.gov)Apr 24, 20202025-09 (estimated)
NCT05846113Renasight Clinical Application, Review and Evaluation (RenaCARE) StudyNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Jun 7, 20212025-08 (estimated)
NCT01545674Prenatal Non-invasive Aneuploidy Test Utilizing SNPs TrialNot listedTerminated2012-012014-04 (actual)
NCT02381457SNP-based Microdeletion and Aneuploidy RegisTry (SMART)Not listedCompleted2015-042020-06 (actual)
NCT01852708Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal BloodNot listedCompleted2012-112020-10 (actual)
NCT03485651Natera Ovarian Cancer Detection AssayNot listedTerminatedDec 14, 2017Nov 1, 2019 (actual)
NCT02278536Multiple Gestation StudyNot listedCompleted2013-032019-03 (actual)
NCT02109770Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNANot listedCompleted2012-102019-06 (actual)
NCT02278874High Risk Multiple Gestation StudyNot listedCompleted2014-08Dec 1, 2018 (actual)
NCT01194531Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh TransferPhase 4Terminated2010-092013-04 (actual)
NCT01023048Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)Not phased (device or behavioral study)Completed2009-112014-03 (actual)
NCT01546324Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic TestingNot listedCompleted2012-022012-05 (actual)
NCT01663584Multi-disease Carrier Screening Test ValidationNot listedWithdrawn2012-082013-06 (actual)
NCT01197872Clinical Use of Parental Support To Detect Single Gene MutationsNot listedCompleted2010-092013-06 (actual)
NCT01574781Non-invasive Prenatal Diagnostic Validation StudyNot listedCompleted2011-092013-04 (actual)

NIH awards 11

Annual award amounts. Total $5.7M.

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Connect

See your connections at Natera on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12

Feedback